The Platinum Study Comparison Group

Status Completed

Clinical Trial Summary

The patients enrolled on this new study will serve as an appropriate comparison group consisting of patients with the diagnosis of germ cell testicular cancer who were cured with surgical resection and did not receive cisplatin-based chemotherapy with a group of patients from another study who did receive cisplatin-based chemotherapy.

Clinical Trial Description

Primary Objective

To compare the prevalence of ototoxicity and neurotoxicity in GCT cancer survivors who only had surgery to a similar population from The Platinum Study (RSRB45410/1305011509) who received cisplatin-based combination chemotherapy.

Secondary Objective

To compare the prevalence of obesity, hypertension, and use of antidepressants/anxiolytics in GCT cancer survivors who only had surgery to a similar population from The Platinum Study who received cisplatin-based combination chemotherapy. ;

Study Design

Related Conditions & MeSH terms

Testicular Neoplasms

Clinical Trial Details

NCT number	NCT02890030
Study type	Observational
Source	Indiana University
Contact
Status	Completed
Phase
Start date	May 2015
Completion date	June 14, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00231582` - High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II	Phase 2
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Terminated	`NCT02577172` - Testicular Cancer and Aerobic and Strength Training	N/A
Completed	`NCT03403777` - Avelumab in Refractory Testicular Germ Cell Cancer.	Phase 2
Recruiting	`NCT05264337` - Lymphedema After Urologic Surgery
Active, not recruiting	`NCT03426865` - Role of Axumin PET Scan in Germ Cell Tumor
Completed	`NCT00001270` - Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma	Phase 1
Completed	`NCT02459132` - High-Intensity Aerobic Interval Training in Testicular Cancer Survivors	N/A
Completed	`NCT06309732` - GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)	Phase 2
Terminated	`NCT02499952` - Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors	Phase 2
Recruiting	`NCT02304575` - Quality of Life Among Testicular Cancer Survivors	N/A
Withdrawn	`NCT02492360` - Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy	N/A
Completed	`NCT04122430` - Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
Recruiting	`NCT02229916` - Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
Completed	`NCT02161692` - Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors	Phase 2
Completed	`NCT02966509` - Engagement of Patients With Advanced Cancer	N/A
Recruiting	`NCT02341989` - Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer	Phase 3
Completed	`NCT05056688` - Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors	N/A
Terminated	`NCT05229900` - A Study of SGN-ALPV in Advanced Solid Tumors	Phase 1
Completed	`NCT00123773` - Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence	Phase 2